NeuACT, a Phase 2 randomised, open-label trial of DN24-02 in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence: Updated analysis of product parameters and safety Meeting Abstract
| Authors: | Bajorin, D.; Sharma, R.; O'Donnell, P. H.; Sims, R.; DeVries, T.; Sheikh, N.; Gomella, L. G. |
| Abstract Title: | NeuACT, a Phase 2 randomised, open-label trial of DN24-02 in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence: Updated analysis of product parameters and safety |
| Meeting Title: | 17th European Cancer Conference (ECCO 17) |
| Journal Title: | European Journal of Cancer |
| Volume: | 49 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Sep 27-Oct 1 |
| Meeting Location: | Amsterdam, Netherlands |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-09-01 |
| Start Page: | S699 |
| Language: | English |
| ACCESSION: | WOS:000326843604269 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(13)70064-9 |
| Notes: | Meeting Abstract: 2907 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos |
